Nano-X Imaging's Nanox.ARC scanner received expanded FDA clearance, potentially boosting sales and deployments, but financial challenges and poor past performance warrant caution. Despite recent ...
Nano-X Imaging has seen a significant decline in stock value, shedding over 37% since February, with no strong catalysts to reverse the trend. Nvidia’s small stake in Nano-X briefly boosted the stock, ...
Nano-X Imaging (NASDAQ: NNOX), the Israeli X-ray imaging company that hopes to disrupt the medical devices market with a business model charging per X-ray delivered rather than simply selling X-ray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results